One example is nanoparticles that have been formulated with gadolinium, which is also used as a non-nanomaterial contrast agent in MRI. Gadolinium ions have been incorporated into various nano-scaffolds consisting of polymers, micelles, liposomes, carbon nanotubes, lipoproteins, and silica nanoparticles. These contrast agents show increased sensitivity as the magnetic fields concentrate the ions in and around the tissue of interest. Gadolinium chelates are usually in macrocyclic form to prevent leaching out of gadolinium ions, which can cause nephrotoxicity. Gadolinium based nanomaterials are used in T1-weighted MRI because of the gadolinium is paramagnetic, and the contrast produced is positive in nature. This makes gadolinium based nanomaterials very useful in areas with unpredictable structure and possible signal voids, like the abdomen. Gadolinium has also been combined with dendrimers to produce MRI contrast agents. Dendrimer based contrast agents, like gadolinium-PAMAM Starbust dendrimer, have a longer half-life than common gadolinium based contrast agents, and can have high molecular relaxivity. The larger dendrimers have difficulty being cleared from the liver, and retention of these contrast agents is
One example is nanoparticles that have been formulated with gadolinium, which is also used as a non-nanomaterial contrast agent in MRI. Gadolinium ions have been incorporated into various nano-scaffolds consisting of polymers, micelles, liposomes, carbon nanotubes, lipoproteins, and silica nanoparticles. These contrast agents show increased sensitivity as the magnetic fields concentrate the ions in and around the tissue of interest. Gadolinium chelates are usually in macrocyclic form to prevent leaching out of gadolinium ions, which can cause nephrotoxicity. Gadolinium based nanomaterials are used in T1-weighted MRI because of the gadolinium is paramagnetic, and the contrast produced is positive in nature. This makes gadolinium based nanomaterials very useful in areas with unpredictable structure and possible signal voids, like the abdomen. Gadolinium has also been combined with dendrimers to produce MRI contrast agents. Dendrimer based contrast agents, like gadolinium-PAMAM Starbust dendrimer, have a longer half-life than common gadolinium based contrast agents, and can have high molecular relaxivity. The larger dendrimers have difficulty being cleared from the liver, and retention of these contrast agents is